Mereo BioPharma Group plc (LON: 0A9G)
London
· Delayed Price · Currency is GBP · Price in USD 2.969
+0.024 (0.81%)
At close: Jan 22, 2025
Mereo BioPharma Group Revenue
Mereo BioPharma Group had revenue of $1.00M USD in the twelve months ending September 30, 2024, down -88.89% year-over-year. In the year 2023, Mereo BioPharma Group had annual revenue of $10.00M.
Revenue (ttm)
$1.00M
Revenue Growth
-88.89%
P/S Ratio
n/a
Revenue / Employee
$30.30K
Employees
33
Market Cap
367.25M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 221.41B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |